---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-056598"
form_type: "8-K"
ticker: "ARMP"
cik: "0000921114"
company_name: "Armata Pharmaceuticals, Inc."
filed_at: "2023-05-05T23:59:59+00:00"
generated_at: "2026-06-15T19:04:17.026072+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Armata terminates CFO Erin Butler, appoints Julianne Averill as CFO via Danforth Advisors

## Summary
- Erin Butler terminated May 1, 2023 in connection with planned closure of San Diego office.
- Julianne Averill appointed CFO effective May 2, 2023; serves as principal financial and accounting officer.
- Averill, age 38, is a senior director at Danforth Advisors with 20+ years finance leadership.
- Company pays Danforth $395/hour for Averill's services; no direct compensation to Averill.

## SEC filing metadata
- accession: 0001104659-23-056598
- form_type: 8-K
- ticker: ARMP
- cik: 0000921114
- company_name: Armata Pharmaceuticals, Inc.
- filed_at: 2023-05-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921114/000110465923056598/0001104659-23-056598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921114/000110465923056598/tm2313321d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-056598
- JSON: https://secwatch.observer/filing/0001104659-23-056598.json
- Plain text: https://secwatch.observer/filing/0001104659-23-056598.txt

## Key facts
- Executive change
  Julianne Averill was appointed as Chief Financial Officer at Armata Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On May 4, 2023, the Company’s Board of Directors (the “ Board ”) appointed Julianne Averill to serve, effective as of May 2, 2023, as Chief Financial Officer of the Company and in such capacity, also serve as principal financial officer and principal accounting officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921114/000110465923056598/0001104659-23-056598-index.htm
- Executive change
  Erin Butler was terminated as Vice President, Finance and Administration at Armata Pharmaceuticals, Inc..
  - Action: terminated
  - Role: Vice President, Finance and Administration
  source text: On May 1, 2023 (the “ Termination Date ”), in connection with the planned closure of the Company’s San Diego, CA office, Armata Pharmaceuticals, Inc. (the “ Company ”) terminated the employment of Erin Butler, Vice President, Finance and Administration (and principal financial officer and principal accounting officer) of the Company, effective as of close of business on the Termination Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921114/000110465923056598/0001104659-23-056598-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.